Tumor angiogenesis / / edited by Sophia Ra.

Tumor angiogenesis is the main process responsible for the formation of new blood vessels that promote tumor growth and metastasis. This process is driven by potent pro-angiogenic factors that are predominant in the tumor environment and are produced by both malignant cells and the host cells recrui...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Rijeka, Croatia : : IntechOpen,, [2012]
©2012
Year of Publication:2012
Language:English
Physical Description:1 online resource (308 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545805204498
ctrlnum (CKB)4970000000097614
(NjHacI)994970000000097614
(oapen)https://directory.doabooks.org/handle/20.500.12854/65578
(EXLCZ)994970000000097614
collection bib_alma
record_format marc
spelling Ran, Sophia edt
Tumor angiogenesis / edited by Sophia Ra.
IntechOpen 2012
Rijeka, Croatia : IntechOpen, [2012]
©2012
1 online resource (308 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (InTech, viewed October 12, 2022).
Includes bibliographical references.
Tumor angiogenesis is the main process responsible for the formation of new blood vessels that promote tumor growth and metastasis. This process is driven by potent pro-angiogenic factors that are predominant in the tumor environment and are produced by both malignant cells and the host cells recruited to the tumor site. Tumor environment is characterized by the imbalance between pro-angiogenic and anti-angiogenic factors, which drives the construction of numerous but structurally defective vessels. These poorly perfused and abnormal vessels significantly contribute to the tumor pathology not only by supporting the expansion of the tumor mass but also by promoting chronic inflammation, enhancing thrombosis, impeding drug delivery, and disseminating tumor cells. These problems associated with tumor vasculature continue to attract great attention of scientists and clinicians interested in advancing the understanding of tumor biology and development of new drugs. This book complies a series of reviews that cover a broad spectrum of current topics related to the pathology of tumor blood vessels including mechanisms inducing new vessels, identification of new targets for inhibition of tumor angiogenesis, and potential clinical use of known and novel anti-angiogenic therapies. The book provides an update on tumor angiogenesis that could be useful for oncologists, cancer researchers and biologists with interests in vascular and endothelial cell behavior in the context of cancer.
English
Tumors Growth.
Oncology
953-51-0009-2
Ra, Sophia, editor.
language English
format eBook
author2 Ra, Sophia,
author_facet Ra, Sophia,
author2_variant s r sr
s r sr
author2_role TeilnehmendeR
title Tumor angiogenesis /
spellingShingle Tumor angiogenesis /
title_full Tumor angiogenesis / edited by Sophia Ra.
title_fullStr Tumor angiogenesis / edited by Sophia Ra.
title_full_unstemmed Tumor angiogenesis / edited by Sophia Ra.
title_auth Tumor angiogenesis /
title_new Tumor angiogenesis /
title_sort tumor angiogenesis /
publisher IntechOpen
IntechOpen,
publishDate 2012
physical 1 online resource (308 pages) : illustrations
isbn 953-51-6795-2
953-51-0009-2
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC254
callnumber-sort RC 3254.6 T866 42012
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.992
dewey-sort 3616.992
dewey-raw 616.992
dewey-search 616.992
work_keys_str_mv AT ransophia tumorangiogenesis
AT rasophia tumorangiogenesis
status_str n
ids_txt_mv (CKB)4970000000097614
(NjHacI)994970000000097614
(oapen)https://directory.doabooks.org/handle/20.500.12854/65578
(EXLCZ)994970000000097614
carrierType_str_mv cr
is_hierarchy_title Tumor angiogenesis /
author2_original_writing_str_mv noLinkedField
_version_ 1796649052500131840
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00989nam a2200301 i 4500</leader><controlfield tag="001">993545805204498</controlfield><controlfield tag="005">20221013063655.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221013s2012 ci a ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-6795-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000097614</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000097614</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/65578</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000097614</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC254.6</subfield><subfield code="b">.T866 2012</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.992</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ran, Sophia</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Tumor angiogenesis /</subfield><subfield code="c">edited by Sophia Ra.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2012</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Croatia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2012]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (308 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 12, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tumor angiogenesis is the main process responsible for the formation of new blood vessels that promote tumor growth and metastasis. This process is driven by potent pro-angiogenic factors that are predominant in the tumor environment and are produced by both malignant cells and the host cells recruited to the tumor site. Tumor environment is characterized by the imbalance between pro-angiogenic and anti-angiogenic factors, which drives the construction of numerous but structurally defective vessels. These poorly perfused and abnormal vessels significantly contribute to the tumor pathology not only by supporting the expansion of the tumor mass but also by promoting chronic inflammation, enhancing thrombosis, impeding drug delivery, and disseminating tumor cells. These problems associated with tumor vasculature continue to attract great attention of scientists and clinicians interested in advancing the understanding of tumor biology and development of new drugs. This book complies a series of reviews that cover a broad spectrum of current topics related to the pathology of tumor blood vessels including mechanisms inducing new vessels, identification of new targets for inhibition of tumor angiogenesis, and potential clinical use of known and novel anti-angiogenic therapies. The book provides an update on tumor angiogenesis that could be useful for oncologists, cancer researchers and biologists with interests in vascular and endothelial cell behavior in the context of cancer.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tumors</subfield><subfield code="x">Growth.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-0009-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ra, Sophia,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:37:40 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338024120004498&amp;Force_direct=true</subfield><subfield code="Z">5338024120004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338024120004498</subfield></datafield></record></collection>